Translate Bio, a Lexington-based, clinical-stage mRNA therapeutics company, and Sanofi Pasteur, the vaccines global business unit of Sanofi, have agreed to expand their existing 2018 collaboration and license agreement to develop mRNA vaccines for infectious diseases. The expansion of this agreement will further unite Translate Bio’s expertise and knowledge from more than 10 years of […]

Vaccines work by mimicking disease agents to stimulate the immune system, building up a defense mechanism that remains active in the body to fight future infections. mRNA vaccines offer an innovative approach by delivering a nucleotide sequence encoding the antigen or antigens selected for their high potential to induce a protective immune response. mRNA vaccines […]

Boston-based biotech Akouos has raised gross proceeds of $244 million in its June stock market debut. Akouos is a precision genetic medicine company dedicated to developing gene therapies for people worldwide who live with disabling hearing loss. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery […]

Cambridge-based, venture capital firm Atlas Ventures has raised $400 million to build breakthrough biotech startups in a highly oversubscribed Fund XII fundraise. “The importance of advancing innovations in biotechnology has rarely felt more critical,” said Bruce Booth, partner at Atlas Venture. “We continue to be humbled by the support of the LP community, whose partnership […]